Biocorrx (OTCMKTS:BICX) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Biocorrx (OTCMKTS:BICX – Get Free Report) announced its earnings results on Monday. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.02, Zacks reports.

Biocorrx Stock Performance

OTCMKTS:BICX opened at $0.21 on Monday. The stock has a 50-day simple moving average of $0.22 and a two-hundred day simple moving average of $0.31. Biocorrx has a 52-week low of $0.15 and a 52-week high of $1.28. The firm has a market capitalization of $6.47 million, a PE ratio of -1.76 and a beta of 0.07.

Biocorrx Company Profile

(Get Free Report)

BioCorRx, Inc. is a healthcare company focused on substance-use-disorder treatment and related products. Its BioCorRx Recovery Program is an outpatient approach that combines medication-assisted treatment with counseling and ongoing support for people seeking treatment for alcohol or opioid dependence. The company has also pursued pharmaceutical products intended to support addiction treatment, including long-acting formulations. Its business includes developing treatment offerings and working to make them available through healthcare providers.

Featured Stories

Earnings History for Biocorrx (OTCMKTS:BICX)

Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.